Koers Curative Biotechnology, Inc. Other OTC
Aandelen
CTYX
US20786Q2093
Biotechnologie & Medisch Onderzoek
Omzet 2022 | - | Omzet 2023 | - | Marktkapitalisatie | 13,47 mln. 12,41 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -5 mln. -4,61 mln. | Nettowinst (verlies) 2023 | -3 mln. -2,76 mln. | EV/omzet 2022 | - |
Nettoschuld 2022 | 1,07 mln. 982K | Nettoschuld 2023 | 2,2 mln. 2,03 mln. | EV/omzet 2023 | - |
K/w-verhouding 2022 |
-2,09
x | K/w-verhouding 2023 |
-2,42
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 99,94% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
I. Garr
CEO | Chief Executive Officer | 71 | 11-02-21 |
Paul M. Michael
CHM | Chairman | - | - |
Steve Chizzik
IRC | Investor Relations Contact | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Cary Sucoff
BRD | Director/Board Member | 71 | 12-05-22 |
Theresa Heah
BRD | Director/Board Member | 46 | 31/03 |
Lawrence Zaslow
BRD | Director/Board Member | - | - |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+44,48% | 54,04 mld. | |
+43,57% | 41,96 mld. | |
-0,86% | 41,92 mld. | |
-7,59% | 28,35 mld. | |
+12,30% | 26,35 mld. | |
-21,83% | 19 mld. | |
+7,15% | 13 mld. | |
+29,40% | 12,28 mld. | |
+25,15% | 12,19 mld. |